These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 18058397)

  • 61. Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 x 10(9) cells/L.
    Wood E; Hogg RS; Yip B; Harrigan PR; O'Shaughnessy MV; Montaner JS
    Ann Intern Med; 2003 Nov; 139(10):810-6. PubMed ID: 14623618
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Utilization of medical treatments and adherence to antiretroviral therapy among HIV-positive adults with histories of childhood sexual abuse.
    Meade CS; Hansen NB; Kochman A; Sikkema KJ
    AIDS Patient Care STDS; 2009 Apr; 23(4):259-66. PubMed ID: 19260772
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Alcohol consumption and antiretroviral adherence among HIV-infected persons with alcohol problems.
    Samet JH; Horton NJ; Meli S; Freedberg KA; Palepu A
    Alcohol Clin Exp Res; 2004 Apr; 28(4):572-7. PubMed ID: 15100608
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Nonstructured treatment interruptions among injection drug users in Baltimore, MD.
    Kavasery R; Galai N; Astemborski J; Lucas GM; Celentano DD; Kirk GD; Mehta SH
    J Acquir Immune Defic Syndr; 2009 Apr; 50(4):360-6. PubMed ID: 19214124
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Adherence, stereotyping and unequal HIV treatment for active users of illegal drugs.
    Ware NC; Wyatt MA; Tugenberg T
    Soc Sci Med; 2005 Aug; 61(3):565-76. PubMed ID: 15899316
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Improving treatment adherence in drug abusers who are HIV-positive.
    Malone SB; Osborne JJ
    Lippincotts Case Manag; 2000; 5(6):236-45; quiz 245-7. PubMed ID: 16398004
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Variations in patterns of highly active antiretroviral therapy (HAART) adherence.
    Levine AJ; Hinkin CH; Castellon SA; Mason KI; Lam MN; Perkins A; Robinet M; Longshore D; Newton T; Myers H; Durvasula RS; Hardy DJ
    AIDS Behav; 2005 Sep; 9(3):355-62. PubMed ID: 16088365
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study.
    Nieuwkerk PT; Sprangers MA; Burger DM; Hoetelmans RM; Hugen PW; Danner SA; van Der Ende ME; Schneider MM; Schrey G; Meenhorst PL; Sprenger HG; Kauffmann RH; Jambroes M; Chesney MA; de Wolf F; Lange JM;
    Arch Intern Med; 2001 Sep; 161(16):1962-8. PubMed ID: 11525698
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Integration of motivational interviewing and cognitive behavioral therapy to improve HIV medication adherence and reduce substance use among HIV-positive men and women: results of a pilot project.
    Parsons JT; Rosof E; Punzalan JC; Di Maria L
    AIDS Patient Care STDS; 2005 Jan; 19(1):31-9. PubMed ID: 15665633
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Impact of an adherence program to antiretroviral treatment on virologic response in a cohort of multitreated and poorly adherent HIV-infected patients in Spain.
    Navarro J; Pérez M; Curran A; Burgos J; Feijoo M; Torrella A; Caballero E; Ocaña I; Ribera E; Crespo M; Falcó V
    AIDS Patient Care STDS; 2014 Oct; 28(10):537-42. PubMed ID: 25111167
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Gender moderates the influence of psychosocial factors and drug use on HAART adherence in the context of HIV and childhood sexual abuse.
    Wilson SM; Sikkema KJ; Ranby KW
    AIDS Care; 2014; 26(8):959-67. PubMed ID: 24410324
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Substance use and HIV disease progression in the HAART era: implications for the primary prevention of HIV.
    Carrico AW
    Life Sci; 2011 May; 88(21-22):940-7. PubMed ID: 20934437
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring.
    Arnsten JH; Demas PA; Farzadegan H; Grant RW; Gourevitch MN; Chang CJ; Buono D; Eckholdt H; Howard AA; Schoenbaum EE
    Clin Infect Dis; 2001 Oct; 33(8):1417-23. PubMed ID: 11550118
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Good adherence to HAART and improved survival in a community HIV/AIDS treatment and care programme: the experience of The AIDS Support Organization (TASO), Kampala, Uganda.
    Abaasa AM; Todd J; Ekoru K; Kalyango JN; Levin J; Odeke E; Karamagi CA
    BMC Health Serv Res; 2008 Nov; 8():241. PubMed ID: 19021908
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Impact of short-term adherence on virological and immunological success of HAART: a case study among French HIV-infected IDUs.
    Pradier C; Carrieri P; Bentz L; Spire B; Dellamonica P; Moreau J; Moatti JP
    Int J STD AIDS; 2001 May; 12(5):324-8. PubMed ID: 11368807
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Adherence to antiretroviral therapy among HIV-infected drug users: a meta-analysis.
    Malta M; Magnanini MM; Strathdee SA; Bastos FI
    AIDS Behav; 2010 Aug; 14(4):731-47. PubMed ID: 19020970
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Sustained antiretroviral treatment adherence in survivors of the pre-HAART era: attitudes and beliefs.
    Fumaz CR; Muñoz-Moreno JA; Moltó J; Ferrer MJ; López-Blázquez R; Negredo E; Paredes R; Gómez G; Clotet B
    AIDS Care; 2008 Aug; 20(7):796-805. PubMed ID: 18728987
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Alcohol and drug use severity are independently associated with antiretroviral adherence in the current treatment era.
    Ma J; Luu B; Ruderman SA; Whitney BM; Merrill JO; Mixson LS; Nance RM; Drumright LN; Hahn AW; Fredericksen RJ; Chander G; Lau B; McCaul ME; Safren S; O'Cleirigh C; Cropsey K; Mayer KH; Mathews WC; Moore RD; Napravnik S; Christopoulos K; Willig A; Jacobson JM; Webel A; Burkholder G; Mugavero MJ; Saag MS; Kitahata MM; Crane HM; Delaney JAC
    AIDS Care; 2024 May; 36(5):618-630. PubMed ID: 37419138
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The impact of incarceration upon adherence to HIV treatment among HIV-positive injection drug users: a qualitative study.
    Small W; Wood E; Betteridge G; Montaner J; Kerr T
    AIDS Care; 2009 Jun; 21(6):708-14. PubMed ID: 19806487
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic.
    Lucas GM; Gebo KA; Chaisson RE; Moore RD
    AIDS; 2002 Mar; 16(5):767-74. PubMed ID: 11964533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.